PMA
NVO

Prudent Man Advisors’s Novo Nordisk NVO Stock Holding History

Prudent Man Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,721
Closed -$234K – 176
2024
Q4 		$234K Hold
2,721
– – 0.09% 140
2024
Q3 		$324K Hold
2,721
– – 0.11% 136
2024
Q2 		$388K Buy
2,721
+623
+30% +$82.6K 0.14% 125
2024
Q1 		$269K Sell
2,098
-356
-15% -$42.4K 0.1% 138
2023
Q4 		$254K Sell
2,454
-422
-15% -$41.7K 0.09% 146
2023
Q3 		$262K Sell
2,876
-102
-3% -$8.98K 0.1% 146
2023
Q2 		$241K Hold
2,978
– – 0.09% 162
2023
Q1 		$237K Hold
2,978
– – 0.09% 158
2022
Q4 		$202K Buy
+2,978
New +$175K 0.08% 188

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Prudent Man Advisors's NVO Position: Q1 2025 in Review

Prudent Man Advisors sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 2,721 shares — an estimated $234K sold.

Prudent Man Advisors first reported a position in NVO in Q4 2022 and held it in 9 quarters. The position peaked at $388K in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Prudent Man Advisors reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Prudent Man Advisors sold 2,721 Novo Nordisk shares in Q1 2025, an estimated $234K.
  • Prudent Man Advisors first reported a position in Novo Nordisk in Q4 2022 and held it in 9 quarters.
  • Prudent Man Advisors's Novo Nordisk position peaked at $388K in Q2 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Prudent Man Advisors's 13F filing for Q1 2025, filed 1 May 2025.